Filing Flows › Glaukos (GKOS) › R&D spending
Glaukos (GKOS) R&D spending by quarter
Glaukos' R&D spending was $31.0M in Q3 2026 (third quarter 2026), -40% from Q2 2026. Over the last 7 quarters it ranged from $26.9M (Q3 2025) to $51.3M (Q2 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $31.0M | -40% | +15% |
| Q2 2026 | $51.3M | +16% | +40% |
| Q1 2026 | $44.1M | +1% | +36% |
| Q4 2025 | $43.7M | +63% | — |
| Q3 2025 | $26.9M | -26% | — |
| Q2 2025 | $36.5M | +13% | — |
| Q1 2025 | $32.4M | — | — |
Q3 2026 at a glance
Glaukos, Q3 2026: revenue $211M (+58% year over year), operating margin 0.4%, net earnings $2.0M, operating cash flow $38.6M. The chart follows the revenue to costs, profit and cash.
Questions
What is Glaukos' R&D spending?
Glaukos' R&D spending was $31.0M in Q3 2026 (third quarter 2026), -40% from Q2 2026.
How has Glaukos' R&D spending changed?
Over the last 7 quarters it ranged from $26.9M (Q3 2025) to $51.3M (Q2 2026).